Intellipharmaceutics International Inc. (IPCI)

[fred198484]

No, I am still a sizable investor. And I am therefore hoping they don't shelve Rexista. The only way I see them doing that is if the FDA gives them no path forward, which is a realistic possibility that you should contemplate a little more.

The good news is that even if they do have to shelve Rexista, they have plenty else to work on which could add a tremendous amount of value. I don't own it for the generics, so I tend to discount them (but I like the revenue they can bring in these lean times - hopes its enough). I believe you can justify owning IPCI on PODRA alone. I am not sure why Regbatin has not been partnered yet but that is not inspiring confidence. However, if that too starts moving forward, it would be exciting and also would be enough to justify holding onto my shares.

I am looking for a game plan being laid out to me by the company and an offering that would allow me to average down at an attractive price. I would not mind seeing more professional management as well. A lot could happen in the next month or so. I don't think all of it has to be bad but for myself, I am assuming Rexista is given a CRL by the FDA and that the company refocuses on PODRAS and Regbatin. If I am wrong, and I should be wrong if the facts win the day (unfortunately, they don't always do so as we saw at the ADCOM), all the better. But I am not counting on it.